Premium
Chronic kidney disease is a very significant comorbidity for high risk of death in patients with COVID ‐19 in Mexico
Author(s) -
ParraBracamonte Gaspar Manuel,
ParraBracamonte Francisco E.,
LopezVillalobos Nicolas,
LaraRivera Ana Laura
Publication year - 2021
Publication title -
nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 61
eISSN - 1440-1797
pISSN - 1320-5358
DOI - 10.1111/nep.13827
Subject(s) - medicine , kidney disease , comorbidity , case fatality rate , diabetes mellitus , covid-19 , obesity , population , disease , public health , mortality rate , demography , environmental health , infectious disease (medical specialty) , endocrinology , pathology , sociology
Chronic kidney disease (CKD) is a recognized public health problem and key determinant of poor health outcomes. In Mexico, this condition has been associated with high and significant risk of death in COVID‐19 patients; however, not enough attention has been given to the vulnerable population as the increasing numbers and fatality rates suggest. This study evaluated the effect of interaction between CKD condition and other risk factors (sex, diabetes, hypertension and obesity) on the survival rate of positive patients for COVID‐19 in Mexico. The results from this study support that CKD patients is a population at high risk for mortality for COVID‐19 and that COVID‐19 positive inpatients with CKD and diabetes are highly vulnerable to death.